Vincent Leroy

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Sanofi, Arkema France, Aventis Pharma S.a.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vincent Leroy. Retrieved from https://idiyas.com/inventor/vincent-leroy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 92.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 19(Granted Patents)

Location History:

Nogent sur Marne, FR (2011)
Paris, FR (2012 - 2021)
Fitz James, FR (2018 - 2022)

Company Filing History:

Years Active: 2011-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12692367 - Rheology additives based on di- or tri-amides and mixtures thereof (2026-07-28),

2. 12240795 - Rheological additive based on optionally biosourced 1,5-pentamethylenediamine (2025-03-04),

3. 12195417 - Rheology additives based on hydroxylated di-or tri-amides and mixtures therof (2025-01-14),

4. 11485834 - Fatty diamide additive composition preconcentrated and pre-activated in a reactive diluent (2022-11-01),

5. 10980816 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2021-04-20),

6. 10736904 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2020-08-11),

7. 10500212 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2019-12-10),

8. 10220044 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2019-03-05),

9. 9868848 - Additives made from fatty diamides for nucleophile-sensitive cross-linkable compositions (2018-01-16),

10. 9744176 - Therapeutic uses of novel thienopyrimidine derivatives (2017-08-29),

11. 9115140 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof (2015-08-25),

12. 8314121 - Imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular CDC7 (2012-11-20),

13. 8058290 - 7-substituted aza-indazoles, compositions containing same, production method and use thereof (2011-11-15),

Title: Vincent Leroy: A Pioneer in Thienopyrimidine Derivatives

Introduction

Vincent Leroy is an accomplished inventor based in Paris, France, known for his contributions to pharmaceutical chemistry. With a remarkable portfolio of 8 patents, Leroy has established himself as a significant figure in the field of medicinal compounds, particularly focusing on thienopyrimidine derivatives.

Latest Patents

Among his latest innovations are patents related to thienopyrimidine derivatives, which encompass the processes for their preparation and therapeutic applications. These inventions involve compounds of specific structural formulas, demonstrating versatility with groups such as substituted phenyl or heteroaryl, along with processes that enable their synthesis and application in therapy. This work underscores Leroy’s commitment to advancing pharmaceutical science through innovative compounds.

Career Highlights

Vincent Leroy has made a significant impact in the pharmaceutical industry by working with notable companies including Sanofi and Aventis Pharma S.A. His tenure at these organizations has allowed him to be at the forefront of drug development and innovation. His expertise in the field has not only contributed to the company's success but also to the advancement of healthcare through novel therapeutic agents.

Collaborations

Throughout his career, Leroy has collaborated with esteemed colleagues, including Jean-Christophe Carry and Fabienne Chatreaux. These partnerships highlight the collaborative effort often required in the innovation process, enabling the combination of diverse expertise to yield remarkable advancements in medicinal chemistry.

Conclusion

Vincent Leroy's work on thienopyrimidine derivatives exemplifies the type of innovative thinking that propels the pharmaceutical industry forward. With a strong record of patents and influential collaborations, he continues to contribute to the evolution of drug development and therapeutic solutions, solidifying his reputation as a leading inventor in his field.

Profile summary based on public USPTO records.